Literature DB >> 19089361

Prospective isolation of mesenchymal stem cells from mouse compact bone.

Brenton J Short1, Nathalie Brouard, Paul J Simmons.   

Abstract

Bone marrow from numerous species, including rodents and man, has been shown to contain a rare population of cells known as marrow stromal cells or mesenchymal stem cells (MSC). Given the innate ability of these cells to give rise to multiple tissue types including bone, fat and cartilage, there is considerable interest in utilizing MSC in a broad repertoire of cell-based therapies for the treatment of human disease. In order for such therapies to be realized, a preclinical animal model in which to refine strategies utilizing MSC is required.We have described methodology allowing for the prospective isolation by fluorescence activated cell sorting (FACS) of a highly purified population of MSC from murine compact bone (CB). These cells are multipotent and capable of extensive proliferation in vitro and thus represent an ideal source of cells with which to explore both the fundamental biology of MSC and their efficacy in a variety of cellular therapies.

Entities:  

Mesh:

Year:  2009        PMID: 19089361     DOI: 10.1007/978-1-59745-060-7_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  35 in total

1.  Isolation of the stromal-vascular fraction of mouse bone marrow markedly enhances the yield of clonogenic stromal progenitors.

Authors:  Colby Suire; Nathalie Brouard; Karen Hirschi; Paul J Simmons
Journal:  Blood       Date:  2012-01-18       Impact factor: 22.113

Review 2.  The role of Eph/ephrin molecules in stromal–hematopoietic interactions.

Authors:  Thao M Nguyen; Agnieszka Arthur; Stan Gronthos
Journal:  Int J Hematol       Date:  2016-02       Impact factor: 2.490

Review 3.  Anti-fibrogenic strategies and the regression of fibrosis.

Authors:  Tatiana Kisseleva; David A Brenner
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

4.  Mobilization of endogenous stem cell populations enhances fracture healing in a murine femoral fracture model.

Authors:  Chrisoula A Toupadakis; Jennifer L Granick; Myrrh Sagy; Alice Wong; Ehssan Ghassemi; Dai-Jung Chung; Dori L Borjesson; Clare E Yellowley
Journal:  Cytotherapy       Date:  2013-07-03       Impact factor: 5.414

5.  Investigating global gene expression changes in a murine model of cherubism.

Authors:  Tulika Sharma; Justin Cotney; Vijender Singh; Archana Sanjay; Ernst J Reichenberger; Yasuyoshi Ueki; Peter Maye
Journal:  Bone       Date:  2020-03-10       Impact factor: 4.398

Review 6.  Haematopoietic stem cell activity and interactions with the niche.

Authors:  Sandra Pinho; Paul S Frenette
Journal:  Nat Rev Mol Cell Biol       Date:  2019-05       Impact factor: 94.444

7.  Isolation of murine bone marrow derived mesenchymal stem cells using Twist2 Cre transgenic mice.

Authors:  Yaling Liu; Liping Wang; Reza Fatahi; Mark Kronenberg; Ivo Kalajzic; David Rowe; Yingcui Li; Peter Maye
Journal:  Bone       Date:  2010-07-27       Impact factor: 4.398

8.  Molecular characterization of prospectively isolated multipotent mesenchymal progenitors provides new insight into the cellular identity of mesenchymal stem cells in mouse bone marrow.

Authors:  Hong Qian; Aurora Badaloni; Francesca Chiara; Jenny Stjernberg; Naresh Polisetti; Kristian Nihlberg; G Giacomo Consalez; Mikael Sigvardsson
Journal:  Mol Cell Biol       Date:  2012-11-26       Impact factor: 4.272

9.  Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms.

Authors:  Kang Cheng; Partab Rai; Andrei Plagov; Xiqian Lan; Dileep Kumar; Divya Salhan; Shabina Rehman; Ashwani Malhotra; Kuldeep Bhargava; Christopher J Palestro; Sanjeev Gupta; Pravin C Singhal
Journal:  Exp Mol Pathol       Date:  2013-03-25       Impact factor: 3.362

10.  Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo.

Authors:  Yi Shen; Ingrid G Winkler; Valerie Barbier; Natalie A Sims; Jean Hendy; Jean-Pierre Lévesque
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.